Key Highlights
● Healthcare Triangle cut its maximum equity-line draw per notice from $2.5 million to $250,000 in a September 22, 2026 amendment.
● The minimum share price required to draw on the Facility rose from $0.01 to $0.10 per share under the amended terms.
● A new provision blocks further put notices if the company undergoes a defined Change of Control Transaction.
● The filing does not explain why the parties agreed to shrink the facility or raise its price floor.
Healthcare Triangle, Inc. (NASDAQ:HCTI) sharply cut back the size of its Equity financing facility with Hudson Global Ventures, LLC, reducing the maximum amount it can draw per notice from $2.5 million to $250,000 and raising the minimum share price required for a draw from $0.01 to $0.10, according to an 8-K filed September 25, 2026. The First Amendment to the companies' Equity Purchase Agreement, originally signed June 12, 2026, was executed September 22 and disclosed in the 8-K's Item 1.01, covering entry into a material definitive agreement.
What Changed in the Agreement
The amendment, filed as Exhibit 10.1, revises several provisions of the original equity line agreement. Under Section 2.1, the maximum "Put Amount" the company can require Hudson Global to purchase per notice drops tenfold, from $2,500,000 to $250,000. Under Section 7.1(o), the minimum share price at which Healthcare Triangle can issue a put notice rises from $0.01 to $0.10 per share, subject to adjustment for stock splits, dividends or similar events.
The amendment also adds a new restriction under Section 5: Healthcare Triangle loses its right to deliver further put notices if the company undergoes a "Change of Control Transaction," which the agreement defines broadly to include an Acquisition of more than 50% voting control, a Merger that leaves original shareholders below 66% ownership, a substantial sale of assets, replacement of more than half the board within three years, or entering into an agreement providing for any of those events. All other sections of the original agreement, including its overall term and the mechanics for delivering put notices, remain unchanged except as specifically modified by these provisions.
What the Filing Doesn't Explain
Neither the 8-K nor the amendment itself states why the parties agreed to shrink the facility and raise its price floor. Equity purchase agreements, sometimes called equity lines, let a company sell stock to an investor over time at prices tied to the market price, giving flexible access to Capital but often at dilutive terms when share prices are low. A minimum price floor protects the company from having to sell shares too cheaply, while a smaller maximum put amount limits how much dilution can occur in any single draw.
The change could reflect a mutual decision to right-size the facility to the company's current stock price and capital needs, but the filing offers no explicit rationale, and all other terms of the original June 12, 2026 agreement remain in effect except as expressly amended. It is also possible the change was requested by Hudson Global itself to limit its own exposure to a thinly traded, low-priced stock, though the filing does not attribute the amendment to either party's request.
Healthcare Triangle's Business
Healthcare Triangle is classified under SIC code 7373, computer systems design services, and is a Delaware corporation; Hudson Global Ventures is a Nevada-based Investment firm. The original equity purchase agreement gave Healthcare Triangle the ability to require Hudson Global to buy shares over time as a financing mechanism, a structure commonly used by smaller public companies without ready access to traditional capital markets. Healthcare Triangle provides cloud, data and digital transformation services to healthcare and life-sciences organizations.
Financing Access Now Tied to Stock Price
The new $0.10 minimum share price will determine whether Healthcare Triangle can draw on the facility at all if its stock trades below that level. The new Change of Control restriction would cut off this financing source entirely if the company pursues a sale, merger or major board turnover. The filing does not disclose whether Healthcare Triangle has drawn on the facility to date or plans to do so under the amended terms, nor does it disclose an expiration date for the underlying agreement.






Please wait processing your request...